A noncoding RNA modulator potentiates phenylalanine metabolism in mice

The functional role of long noncoding RNAs (lncRNAs) in inherited metabolic disorders, including phenylketonuria (PKU), is unknown. Here, we demonstrate that the mouse lncRNA and human associate with phenylalanine hydroxylase (PAH). -knockout mice exhibited excessive blood phenylalanine (Phe), musty...

Full description

Saved in:
Bibliographic Details
Published inScience (American Association for the Advancement of Science) Vol. 373; no. 6555; pp. 662 - 673
Main Authors Li, Yajuan, Tan, Zhi, Zhang, Yaohua, Zhang, Zhao, Hu, Qingsong, Liang, Ke, Jun, Yao, Ye, Youqiong, Li, Yi-Chuan, Li, Chunlai, Liao, Lan, Xu, Jianming, Xing, Zhen, Pan, Yinghong, Chatterjee, Sujash S, Nguyen, Tina K, Hsiao, Heidi, Egranov, Sergey D, Putluri, Nagireddy, Coarfa, Cristian, Hawke, David H, Gunaratne, Preethi H, Tsai, Kuang-Lei, Han, Leng, Hung, Mien-Chie, Calin, George A, Namour, Fares, Guéant, Jean-Louis, Muntau, Ania C, Blau, Nenad, Sutton, V Reid, Schiff, Manuel, Feillet, François, Zhang, Shuxing, Lin, Chunru, Yang, Liuqing
Format Journal Article
LanguageEnglish
Published United States The American Association for the Advancement of Science 06.08.2021
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:The functional role of long noncoding RNAs (lncRNAs) in inherited metabolic disorders, including phenylketonuria (PKU), is unknown. Here, we demonstrate that the mouse lncRNA and human associate with phenylalanine hydroxylase (PAH). -knockout mice exhibited excessive blood phenylalanine (Phe), musty odor, hypopigmentation, growth retardation, and progressive neurological symptoms including seizures, which faithfully models human PKU. depletion led to reduced PAH enzymatic activities in human induced pluripotent stem cell-differentiated hepatocytes. Mechanistically, modulated the enzymatic activities of PAH by facilitating PAH-substrate and PAH-cofactor interactions. To develop a therapeutic strategy for restoring liver lncRNAs, we designed GalNAc-tagged lncRNA mimics that exhibit liver enrichment. Treatment with GalNAc- mimics reduced excessive Phe in and mice and improved the Phe tolerance of these mice.
Bibliography:Author contributions: L.Q.Y. and C.R.L. conceived the project and designed the experiments. Y.J.L. executed the primary studies. Y.J.L. developed genetic mouse models and related experiments with assistance of Q.S.H. and Y.H.Z. T.K.N., X.Z., L.C.L., H.H., L.L. and J.M.X. Z.T. and S.Z. performed the proteomics and modeling studies. J.Y., Y.Q.Y., Z.Z. and L.H. performed bioinformatics analysis. The histological staining and corresponding analysis were performed by Y.J.L. with assistance of K.L. D.H. executed mass spectrometry analysis. CLIP assay were performed by L.Q.Y., S.S.C., Y.H.P. and P.H.G. Metabolic profiling were performed and analyzed by N. P. and analyzed by C.C. Clinical specimens were ascertained and processed by F.N., J.L.G., F.F. with assistance of M.S. an L.Q.Y. Protein purification were performed by Y.J.L. with assistance of Y.C.L. and K.L.T., S.Z. M.C.H., G.A.C., M.S., A.C.M., N.B., V.R.S. and F.F. contributed to experimental design and data interpretation. S.D.E. assisted with manuscript drafting. L.Q.Y. and C.R.L. wrote the manuscript.
Contribute equally
ISSN:0036-8075
1095-9203
DOI:10.1126/science.aba4991